FDA Inspection
WES Pharma Inc.WES Pharma Inc. – FDA Inspection, Dec 13, 2018
Record Details
This FDA Inspection record concerns WES Pharma Inc., with an inspection on December 13, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6e7f00ec-be3e-4dc9-b0b3-70688bdd39f6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1074942
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.42(c)(2)Rejected Material Area
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of WES Pharma Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 20, 2025 | VAI | Baltimore District Office | Drug Quality Assurance |
| November 21, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 18, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 20, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for WES Pharma Inc.
- FDA Inspection 1290200 - 2025-11-20
- FDA Inspection 1223324 - 2023-11-21
- FDA Inspection 1162565 - 2022-02-18
- FDA Inspection 1141774 - 2021-04-28
- FDA Inspection 1114327 - 2019-12-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.